$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

A Case Report of Efficacy of Growth Height and Peak-Luteinizing Hormone Level Suppression on Idiopathic Gonadotropin-Dependent Precocious Puberty Patient Using Herbal Remedy, Aesopjiyoun-tang 원문보기

Journal of Korean Medicine = 대한한의학회지, v.36 no.4, 2015년, pp.150 - 155  

Nam, Se-hion (Aesop Hospital of Korean Medicine) ,  Lee, Chong-hai (Aesop Hospital of Korean Medicine) ,  Tang, Yu-wei (Aesop Clinic of Korean Medicine) ,  Liu, Yuan-sheng (Aesop Clinic of Korean Medicine) ,  Kim, Ki-chul (Aesop Clinic of Korean Medicine) ,  Chun, Sang-yeol (Busan Aijoa Clinic of Korean Medicine) ,  Yeom, Yu-rim (Aesop Naple Clinic of Korean Medicine) ,  Kim, Hyung chang (Gamchodang-Aesop pibro Clinic of Korean Medicine) ,  Lee, Myoung-deok (Aesop Hospital of Korean Medicine)

Abstract AI-Helper 아이콘AI-Helper

The purpose of this report is to evaluate effect of Korean medical treatment on idiopathic gonadotropin-dependent precocious puberty (G-DPP) patient received herbal medicine. We administered Aesopjiyoun-tang remedy to idiopathic G-DPP and analyzed the delay effect by hormonal value and radiographs; ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • This case study evaluated LHL, MGV duration of both herbal treatment and after cessation of treatment. It was to report to obtain significant results through the patient with G-DPP who were visited hospital of Korean Medicine for herbal treatment.

대상 데이터

  • An 8-year-old girl was diagnosed with GDPP on Sep. 2014 in OO hospital near home. The pediatrician recommended GnRH treatment, but guardian refused due to anxiety about the adverse effect.
본문요약 정보가 도움이 되었나요?

참고문헌 (19)

  1. Carel JC, Leger J. Precocious puberty. The New England journal of medicine. 2008;358:2366 77. 

  2. Martin R. Early puberty: what is normal and when is treatment indicated. Horm. Res. 2003;60 (suppl3):31-4. 

  3. Brown JJ, Warne GL. Growth in precocious puberty. Indian journal of pediatrics. 2006;73:81-88. 

  4. Gluckman PD, Hanson MA. Evolution, development and timing of puberty. Trends in endocrinology and metabolism. 2006;17(1):7-12. 

  5. Lazar L, Kauli R, Pertzelan A, Phillip M. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab. 2002;87:2090-4. 

  6. Kim TH, Coe HJ, Kim S, Lee SW, Chae HW, Kim YS, et.,al. Cinical and Endocrinologic Characteristics of Children Referred for Precocious Puberty. Korean J of pediatrics. 2007;12(2):119-26. 

  7. Styne D, Grumbach M. Puberty: ontogeny, neuroendocri-nology, physiology, and disorders. In: Kronenberg HM, Mel-med S, Polonsky KS, Larsen PR, editors. Williams textbook of endocrinology. 11th ed. Philadelphia: Saunders Co. 2008:969-1166. 

  8. Heger S, Muller M, Ranke M, Schwarz HP, Waldhauser F, Partsch CJ, et al. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Mol Cell Endocrinol. 2006;254-255:217-20. 

  9. Lim YK, Hur KW, Park SY, Suh KS, Chun SY, Lee SJ, et al. A Case Report of Precocious Puberty in a Female Patient : Significant Improvement in Controlling the Sex Hormone Levels. J Pediatr Korean Med. 2014;28(4):64-70. 

  10. Kim JE, Yang SJ, Cho SH, Park HM. A report on the effect of jowisengchung-tang in 2 cases of precocious puberty. J Korean obstet gynecol. 2013;26(2):178-187. 

  11. Tanner JM, Healy MJR, Goldstein H. Assessment of skeletal maturity and prediction of adult height. Oxford: Elsevier United Kingdom. 2001. 

  12. Carel JC, Roger M, Ispas S, Tondu F, Lahlou N, Blumberg J, et al. Final Height after Long-Term Treatment with Triptorelin Slow Release for Central Precocious Puberty: Importance of Statural Growth after Interruption of Treatment. J Clin Endocrinol Metab. 1999;84(6):1973-8. 

  13. Mul D, Oostdijk W, Otten BJ, Rouwe C, Jansen M, Delemarre-van de Waal HA, et al. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: the Dutch experience. J Pediatr Endocrinol Metab. 2000;13 Suppl 1:765-72. 

  14. Lazar L, Kauli R, Pertzelan A, Phillip M. Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab. 2002;87(5): 2090-4. 

  15. Partsch CJ, Hummelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, et al. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty influence on growth and predicted adult height. Horm Res. 1993;39:111-7. 

  16. Carel JC, Lahlou N, Guazzarotti L, Joubert -Collin M, Roger M, Colle M, et al. Treatment of central precocious puberty with depot leuprorelin. French Leuprorelin Trial Group. Eur J Endocrinol. 1995;132:669-704. 

  17. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR. Consensus statement on the use of gonadotropin releasing hormone analogs in children. Pediatrics. 2009;123:e752-62. 

  18. Mul D, Hughes IA. The use of GnRH agonists in precocious puberty. Eur J Endocrinol. 2008;159:S3-8. 

  19. Zhao J, Yu J. Study on clinical application of kangzao-II recipe in treating girl gonadotropin-releasing hormone dependent sexual precocity. Chinese Journal of Integrated Traditional and Western Medicine. 2003;3:182-84. 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로